PL4166137T3 - Środek leczniczy na stłuszczeniową chorobę wątroby - Google Patents

Środek leczniczy na stłuszczeniową chorobę wątroby

Info

Publication number
PL4166137T3
PL4166137T3 PL21858322.7T PL21858322T PL4166137T3 PL 4166137 T3 PL4166137 T3 PL 4166137T3 PL 21858322 T PL21858322 T PL 21858322T PL 4166137 T3 PL4166137 T3 PL 4166137T3
Authority
PL
Poland
Prior art keywords
remedy
liver disease
fatty liver
fatty
disease
Prior art date
Application number
PL21858322.7T
Other languages
English (en)
Inventor
Ayatoshi Ando
Ippei KAWANISHI
Seiji Shiraishi
Harumi Tanaka
Yuki Saitou
Original Assignee
Ea Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ea Pharma Co., Ltd. filed Critical Ea Pharma Co., Ltd.
Publication of PL4166137T3 publication Critical patent/PL4166137T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL21858322.7T 2020-08-19 2021-08-18 Środek leczniczy na stłuszczeniową chorobę wątroby PL4166137T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020138703 2020-08-19
PCT/JP2021/030099 WO2022039178A1 (ja) 2020-08-19 2021-08-18 脂肪性肝疾患の治療薬

Publications (1)

Publication Number Publication Date
PL4166137T3 true PL4166137T3 (pl) 2024-08-12

Family

ID=80350445

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21858322.7T PL4166137T3 (pl) 2020-08-19 2021-08-18 Środek leczniczy na stłuszczeniową chorobę wątroby

Country Status (16)

Country Link
US (1) US12023320B2 (pl)
EP (1) EP4166137B1 (pl)
JP (2) JP7286222B2 (pl)
KR (1) KR20230052845A (pl)
CN (1) CN115605198B (pl)
AU (1) AU2021328824A1 (pl)
BR (1) BR112023002069A2 (pl)
CA (1) CA3183428A1 (pl)
DK (1) DK4166137T3 (pl)
ES (1) ES2982263T3 (pl)
FI (1) FI4166137T3 (pl)
MX (1) MX2023001742A (pl)
PL (1) PL4166137T3 (pl)
PT (1) PT4166137T (pl)
TW (1) TWI906348B (pl)
WO (1) WO2022039178A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4732836A1 (en) 2024-10-22 2026-04-29 Consejo Superior De Investigaciones Científicas Ag5 compound for use in the treatment of in fatty liver diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2511271T3 (pl) 2009-12-07 2015-06-30 Ea Pharma Co Ltd Pochodna estru kwasu heteroarylokarboksylowego
ES2618024T3 (es) 2011-06-07 2017-06-20 Ea Pharma Co., Ltd. Derivado de éster de ácido carboxílico heterocíclico
US9024044B2 (en) 2012-06-14 2015-05-05 Ajinomoto Co., Inc. Heteroarylcarboxylic acid ester derivative
EP3118196A4 (en) 2014-03-11 2018-02-21 EA Pharma Co., Ltd. Method for producing heteroarylcarboxylic acid ester derivative, and production intermediate of same
SG11201607555SA (en) 2014-03-11 2016-10-28 Ea Pharma Co Ltd Production method for heteroarylcarboxylic acid ester derivative, production intermediate thereof, and crystal
US10980866B2 (en) * 2014-09-22 2021-04-20 Hadasit Medical Research Services And Development Ltd. Alpha-1 anti-trypsin for treating liver diseases
EP3437651A1 (en) * 2017-08-03 2019-02-06 Université de Strasbourg Peptides for treatment and prevention of nonalcoholic fatty liver disease

Also Published As

Publication number Publication date
US20230201163A1 (en) 2023-06-29
TWI906348B (zh) 2025-12-01
PT4166137T (pt) 2024-06-25
US12023320B2 (en) 2024-07-02
JPWO2022039178A1 (pl) 2022-02-24
EP4166137A4 (en) 2023-06-28
DK4166137T3 (da) 2024-06-17
BR112023002069A2 (pt) 2023-03-07
JP7286222B2 (ja) 2023-06-05
CN115605198A (zh) 2023-01-13
AU2021328824A1 (en) 2023-02-02
JP7756126B2 (ja) 2025-10-17
ES2982263T3 (es) 2024-10-15
FI4166137T3 (fi) 2024-07-01
JP2023103420A (ja) 2023-07-26
CA3183428A1 (en) 2022-02-24
MX2023001742A (es) 2023-02-22
EP4166137A1 (en) 2023-04-19
WO2022039178A1 (ja) 2022-02-24
EP4166137B1 (en) 2024-05-29
TW202214231A (zh) 2022-04-16
KR20230052845A (ko) 2023-04-20
CN115605198B (zh) 2026-04-10

Similar Documents

Publication Publication Date Title
EP4164748C0 (en) CYCLOPROPYL-DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS
EP4493138A4 (en) INGESTED CAPSULES
PL3661373T3 (pl) Kompozycja farmaceutyczna na niedokrwistość
EP4133188C0 (en) NUT MOUNTING MECHANISM
PL4166137T3 (pl) Środek leczniczy na stłuszczeniową chorobę wątroby
JP1775692S (ja) オートディスペンサー
IL309412A (en) Subgingival medicament delivery tray
EP4172142A4 (en) BRANCHED LIPID COMPOUNDS
EP4081296C0 (en) COMPOUNDS DERIVED FROM DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE
EP4652478A4 (en) OPTIMIZATION STRUCTURE
EP4352684C0 (en) OUTPUT PROCESSOR
EP4132559A4 (en) MODIFIED KISSPEPTIN RECEPTOR AGONISTS FOR FATTY LIVER STEATOSIS
EP4463988A4 (en) PHASE 2 SCI DESIGN
ES1304246Y (es) Expositor modular para maquetas
IL316033A (en) Novel composition
ES3054326R1 (es) Calzado desmontable
EP4387785A4 (en) METHOD OF MAKING A MOLD
EP4275555C0 (en) WITHDRAWAL MECHANISM
JP1725001S (ja) 流し台用流し
JP1721986S (ja) 流し台用流し
JP1767487S (ja) レース地
JP1766987S (ja) レース地
UA44129S (uk) Етикетка-наліпка для клейових стрижнів
JP1719186S (ja) ボックスファイル
JP1719202S (ja) ボックスファイル